Elanco Animal Health

ELAN | NYSE

Price Alert Chart Builder DCF Calculator

$22.43

+$0.01 (+0.04%)

At close: Sep 21, 2026, 3:59 PM ET

$22.99

+$0.56 (+2.50%)

Pre-market: Sep 22, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $11.2B

Enterprise Value $14.59B

Beta 1.68

Average Volume 6.34M

Shares Outstanding (Diluted) 505.9M

Shares Change YoY 1.16%

Institutional Ownership N/A

Exchange NYSE

ISIN US28414H1032

Price Performance

Price Change 1M -8.1%

Price Change 3M -3.2%

Price Change 6M -12.0%

Price Change YTD -0.4%

Price Change 1Y 17.9%

Price Change 3Y 99.4%

Price Change 5Y -31.3%

1M CAGR (ann.) -7.4%

1Y CAGR (ann.) 21.6%

5Y CAGR (ann.) -7.7%

All-Time CAGR -5.8%

Valuation

PE Ratio -56.07

Forward PE 17.11

PEG Ratio 0.35

Forward PEG -4.37

PS Ratio 2.23

Forward PS 2.10

PB Ratio 1.70

P/FCF Ratio 32.85

P/Adj. FCF Ratio 45.53

P/OCF Ratio 18.09

EV/Sales 2.91

EV/EBIT 180.10

EV/EBITDA 18.85

EV/FCF 42.78

Earnings Yield -1.8%

FCF Yield 3.0%

Adj. FCF Yield 2.2%

Financial Health

Net Debt $3.39B

Total Debt $3.92B

Cash & Short-Term Investments $530M

Total Assets $13.56B

Current Ratio 2.05

Quick Ratio 1.10

Debt / Equity Ratio 0.59

Debt / EBITDA 5.06

Debt / FCF 11.49

OCF / Debt 0.16

Interest Coverage 1.78

Altman Z-Score 1.31

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 52.6%

Operating Profit Margin 9.2%

EBITDA Margin 15.4%

Net Profit Margin -4.0%

FCF Margin 6.8%

Adj. FCF Margin 4.9%

SBC / Revenue 1.5%

SBC Impact (per share) -27.9%

Returns

Return on Assets -1.5%

Return on Equity -3.0%

Return on Invested Capital 3.9%

Return on Capital Employed 4.0%

Return on Tangible Assets -3.6%

Historical Growth (CAGR)

Revenue CAGR 3Y 5.1%

Revenue CAGR 5Y 2.0%

Revenue CAGR 10Y 5.0%

EPS CAGR 3Y 155.1%

EPS CAGR 5Y 18.2%

EPS CAGR 10Y -7.9%

FCF CAGR 3Y -11.2%

FCF CAGR 5Y 12.3%

FCF CAGR 10Y 18.5%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 21

EPS Growth Next 3Y 162.6%

Revenue Growth Next 3Y 5.9%

Earnings Date Nov 5, 2026

EPS Estimate (next Q) $0.20

EPS Growth Est (next Q) 5.3%

Revenue Est (next Q) $1.21B

Revenue Growth Est (next Q) 6.2%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $28

Price Target Upside 24.8%

Cash Flow

Operating Cash Flow $630M

Free Cash Flow $341M

Adj. Free Cash Flow $246M

FCF Per Share $0.76

OCF Per Share $1.24

OCF/S Ratio 12.3%

Income Statement

Revenue $5.02B

Gross Profit $2.64B

Operating Income $462M

EBITDA $774M

Net Income $-199M

EPS (Diluted) -$0.40

Revenue / Employee $520.21K

Profit / Employee $-20.62K

Employees 9,650